The Europe Magnetoencephalography Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique makes use of the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp. Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments.
MEG scanners have shown to be one of the most valuable pieces of equipment for researching a wide variety of neurological disorders and conditions, including epilepsy, brain tumors, feelings, and the way one experiences pain. The Magnetoencephalography (MEG) technique uses the fact that neuromagnetic impulses are not altered when they travel through the skull and scalp.
Even though the technology has been available for decades, there has been a recent surge in interest in scanners because of computer power and hardware developments. In addition, the increasing number of research and development activities is anticipated to be one of the primary factors that will drive growth in the market for magnetoencephalography scanners throughout the projected period.
The "Medical Informatics" funding scheme, which the German government offers as part of the Health Research Framework Program, provides an opportunity to improve the exchange of data across various institutions and locations. The hope is that more rapid diagnosis and treatment will lead to cost reductions and improved individual access to care that is both quicker and more accurate. These measures taken by regional governments to boost the adoption of cutting-edge medical technology would help the development of the market in the Europe area.
The Germany market dominated the Europe Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $24,285.3 Thousands by 2028. The UK market is exhibiting a CAGR of 4% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.7% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Magnetoencephalography Market will Hit $350.1 Million by 2028, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
By Application
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
